Notifications:
Fellowship in Psycho-Sexual Medicine Examinations - April 2024 - Results (E.No. 0616).
D Pharm Examinations - April 2024 - Results (E.No.0610).
Pharm D Examinations - April 2024 - Results (E.No.0609).
Declaration of Doctor of Philosophy Result - Mr. Kiran K Jadhav.
Previous
Next
U S I C
|
Activities & Events
|
Careers
|
Notifications
|
Site Map
|
Contact Us
( Formerly Known as Jagadguru Sri Shivarathreeshwara University )
Examination
Notifications
Admissions
2024
JSS AHER
Student / Parent / Staff Portal
Center for Online Learning
Show navigation
Hide navigation
ABOUT US
About US
Core Values, Vision and Mission
Chancellor
Pro Chancellor
Vice Chancellor
Registrar
Accreditations & Recognitions
Departments
Regulations & Policies
Committees
CCLPE
RTI
COLLEGES / DEPARTMENTS
Faculty of Medicine
JSS Medical College
School of Public Health
Faculty of Dentistry
JSS Dental College & Hospital
Faculty of Pharmacy
JSS College of Pharmacy, Mysuru
JSS College of Pharmacy, Ooty
Faculty of Biomedical Sciences
Department of Biomedical Sciences
Faculty of Life Sciences
School of Life Sciences, Mysuru
School of Life Sciences, Ooty
Department of Nutrition & Dietetics
Department of Biotechnology and Bioinformatics
Department of Microbiology
Department of Water and Health
Department of Environmental Sciences
Faculty of Management Studies
Department of Health System Management Studies
Faculty of Yoga
Department of Yoga
RESEARCH
PROGRAMS
Academic Programs
UG – Under Graduation
PG - Post Graduation
Doctoral Programs (PhD)
Post Doctoral Programs (D.Sc., D.Litt.)
Diploma Programs
Super Speciality
Certificate Programs
Academic Calendar
STUDENTS
Student Manuals
Anti-Ragging Help
Placement Cell
Student Support Centre
Student Scholarships
Library Information
Campus Facilities
Alumni Engagement
Hostel Facilities
International Students
Regulatory Notifications
Electoral Literacy Clubs
About Mysore
Authorities
NIRF
IQAC
Alumni
JSS Medical College
JSS Dental College and Hospital
JSS College of Pharmacy, Mysuru
JSS College of Pharmacy, Ooty
Department of Health System Management Studies
School of Life Sciences, Mysuru
School of Life Sciences, Ooty
Department of Yoga
CIQA
Outreach
Publications and Patents
Our Recent Publications
Mohammed AfzalAzam, Anjali Singh. Molecular insight into the binding mode of thieno[3,2-c]pyrazol-3-ols with Streptococcus pneumoniaeMurF enzyme by combined molecular modeling approach. StructChem22 Jan’, 2022, https://doi.org/10.1007/s11224-021-01866-z[I.F. : 1.86]
Suresh K, Niladri S, ShyamS, Naresh P, Jubie S, Anticancer potential of phytoconstituents modulating Na+/K+ ATPase pump;A novel repurposing strategy. Current Trends in Biotechnology and Pharmacy,2021.https://doi.org/10.5530/ctbp.2021.3.29
Swarup Rani G, MA Azam, Design, synthesis, antibacterial evaluation and molecular docking studies of some newer baenzothiazole containing aryl and alkarylhydrazides. Chemistry and Biodiversity 2021, 18,e2100117. [I.F. : 2.6]
Swarupa Rani G, MA Azam.GyrB inhibitors as potential antibacterial.Monaschfte fur Chemie. July 2021, 152, 725-744. https://doi.org/10.1007/s00706-021-02800-z [IF 1.591]
Kannan R, Kalirajan R, Baliwada A, PotlapatiV,Gowramma B. Synthetic and semi-synthetic drugs as a promising therapeutic choice for covid-19 treatment- A critical review. Journal of Xian Shiyou University, Natural Sciences Edition, 2021,64(8),ISSN:1673-064X.[I. F. : 0.6]
S.Vadivelan. Jebaseelan, B.EdwinJose, Meera, S.Manikandan,R.Kalirajan,T.Sarojini. Phytochemical investigation and antimicrobial activities of Leaf Extract of Muntingiacalabura Linn. Int.J.Pharm.Sci.Rev.Res. 2021, 69(2),42-46. [Collaborative]
S.Vadivelan. Jebaseelan, B.EdwinJose, Meera, S.Manikandan, R.Kalirajan,T.Sarojini. Hepatoprotective potential of Mimusopselengi L. Leaf Extracts against paracetamol induced Hepatotoxicity in rats. Int.J.Pharm.Sci.Rev.Res. 2021, 69(2),37-41.[Collaborative]
MKMohan MarugaRaja, JubieS, S.Pottabathula, G.V.Anjana and MK.Kathiravan. In silico screening of chemical constituents in Rasam as a beneficial supplementary treatment for novel coronavirus. Journal of Natural Remedies, 2021,DOI:10.18311/jnr/2021/28191. [Collaborative]
PodilaNaresh, Shyam Sunder Pottabatula and JubieSelvaraj. Dengue virus entry/ fusion inhibition by small bioactive molecules: A critical review. Mini-Reveiws in Medicinal Chemistry, 2021,21.1-13. [I.F.: 3.86]
Kalirajan Rajagopal, Vulsibodhya Sri, Kannan Raman, Byrangowramma and Swaminathangomathi. Chalcone substituted 9-anilinoacridines as HER2 inhibitors targeting breast cancer – an in silico approach. International Journal of Pharma Research, 2021, 12(1), 24 -30.
VidyasrilekhaYele, Bharat kumar Reddy, Sanapalli, AfzalAzamMohammed. Imidazoles and benzimidazoles as putative inhibitors of SARS – CoV-2 B.1.17(Alpha) andP.1(Gamma) variant spike glycoproteins: A computational approach. Cheml Papers,2021, https://doi.org/10.1007/s11696-021-01900-8.[I. F.: 2.09]
ShyamSundarP, PodilaNaresh, JawaharNatarajan, AshishWadhwani, SelvarajJubie. Potential CoumarinThiosemicarbazoneHybrids as BRCA – 1Mimetics for ER PositiveBreast Cancer Therapy: An in silico Approach. Journal of Medical Pharmaceutical and Allied Sciences, 2021, I0(4),1383,3484-3493.
R.Kalirajan, VulsiBodhya Sri, Gowramma B.and Swaminathan Gomathi. Pyrazole substituted 9-anilinoacridines as HER2 inhibitors targeting breast cancer – An In –Silico Approaches. Current Drug Research Reviews, 2021 Aug 4. doi: 10.2174/1389557521666210805105146
Swaroop AK, MVNL Ch, Meena S, Subramanian G, Natarajan J,Selvaraj J. Plant derived Immuno modulators; A critical review. Advanced Pharmaceutical Bulletin, doi: 10.34172/apb.2022.074
Deepthi R, MJN Chandrasekar, SB Santhosh, SK Patnaik. Targeting Ovarian Solid Tumors By Elastin-like Polypeptide Drug Conjugates: Current Trends And Future Prospectives. Current Protein and Peptide Science, 22, 2021. visit: https://www.eurekaselect.com/194764/article. [I. F . : 3.272]
S Rajkumar, S Gomathi, C Kannan, B Gowramma, R Sambathkumar. Ground water fluoride induced neurological changes in brain: a promising review.Jornal of Medical Pharmaceutical and Allied Sciences,2021, DOI: 10.22270/jmpas.2021.V10I6.1698. [Collaborative]
Kalirajan R, Gowramma B, Gomathi S, Vadivelan R. Activity of Isoxazole substituted 9-aminoacridines against SARS CoV-2 main protease for COVID19: A computational approach. Jordan Journal of Pharmaceutical Sciences,2021,14(4),403-415.
Jupudi S, Rajagopal Kalirajan, Murugesan S, Kumar BK, Raman K, Byran G, Chennaiah J, Muthiah VP, Dasan P B, Sankaran S. Identification of Papain-Like Protease inhibitors of SARS CoV-2 through HTVS, Molecular docking, MMGBSA and Molecular dynamics approach. S Afr J Bot. 2021 Dec 3. doi: 10.1016/j.sajb.2021.11.033[IF:2.31]
Naresh P, ShyamSundar P, Girija K, Pradheesh SJ, Shanthoshivan AG, Akashwaran S, Swaroop AK &Jubie S. Drug repurposing of Daclatasvir and Famciclovir as antivirals against dengue virus infection by in silico and in vitro techniques. Indian Journal of Biochemistry & Biophysics Vol. 58, December 2021, 557-564.[IF:1.908]
HariBalaji , A. Selvaraj , NiladriSaha , P. ShyamSundar , S. Jubie , S. Dhivya and Suresh K. Mohankumar. Distinct modulation of wild type and selective gene mutated vitamin D receptor by essential poly unsaturated fatty acids. Mini Rev Med Chem 2021;21(17): 2612-2625. doi: 10.2174/1389557521666210104170408 [I.F.: 3.86]
Kaviarasan Lakshmanan, Praveen T K, Sreedhara Ranganath K. Pai, Rajagopal Kalirajan, GowrammaByran. Discovery of potential inhibitors for STAT3: ligand based 3D pharmacophore, virtual screening, molecular docking, dynamic studies and in vitro evaluation. Journal of Biomolecular Structure and Dynamics 2021. 10.1080/07391102.2021.1957717.
Subramanian Gomathy, Ayyamperumal Selvaraj, Chand Jagdish, Jupudi Srikanth, Antony Shanish. Molecular docking studies, in silico admet screening of selected novel azetidine substituted naphthalene’s targeting protease enzyme against SARS cov-19. Journal of Medical Pharmaceutical and Allied Sciences, 2021; 10(6): 3986-3991.
Sherin F, Gomathy S, Antony S. Sirtuin3 in Neurological Disorders. Current Drug Research Reviews. 2021; 13(2):140-147.
Bharat kumar Reddy Sanapalli, VidyasrilekhaYele, Srikanth Jupudi, VeeraVenkataSatyanarayana Reddy Karri. Ligand-based pharmacophore modeling and molecular dynamic simulation approaches to identify putative MMP-9 inhibitors. RSC Advances, 2021; 11: 26820-26831. [IF: 3.3] (Collaborative]
Murugesan R, Sureshkumar R, Radhakrishnan A, Jupudi S, Chennu M. Multiwalled carbon nanotubes as nanomaterial tool in the management of prostate cancer: A possible nanoformulation approach. Advanced Pharmaceutical Bulletin. (Collaborative]
KaviarasanLakshmanan, Elizabeth Eldhose, Praveen Thaggikuppe Krishnamurthy, KalirajanRajagopal, Manal Mohammed, GowrammaByran. 1,3,4-Thiadiazolo (3,2-?) Pyrimidine-6-Carbonitrile Scaffold as PARP1 Inhibitors. Anticancer Agents in Medicinal Chemistry. (10.2174/1871520621999201230233811) 2021, 21(15), 2050-2065. [IF: 2.50]
Senthilkumar Murugesan, kaviarasan lakshmanan, DivyaPamu, Aravindhanathan Venkatesan, VeeraVenkataSatyanarayana Reddy Karri, Byran Gowramma. Once-daily sustained release tablet of zaltoprofen: formulation and evaluation. Journal of Xi`an Shiyou University, Natural Sciences Edition. 2021. DOI: 10.17605/osf.io/94ex8.
Deepthi Ramamurthi1, Jubie Selvaraj1, Sunil Kumar Patnaik1, Nagarjuna Palathoti1 • Raman Rajeshkumar2, Moola Joghee Nanjan Chandrasekar. Synthesisand Characterization of Dipeptide–Drug Conjugate: The Use of Linker Coupling Reaction. International Journal of Peptide Research and Therapeutics, 2022, 28:53,1-9. [IF: 1.90]
Jubie Selvaraj, Shyam Sundar P, Logesh Rajan, Divakar Selvaraj, Dhanabal Palanisamy, Krishnan Namboori PK and Suresh Kumar Mohankumar. Identification of (2R,3R)-2-(3,4-dihydroxyphenyl) chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach. RSC Advances 2021; 11: 13051. (I.F: 3.361)
P. Naresh, A. Selvaraj, P. Shyam Sundar, S. Murugesan, S.Sathianarayanan, Krishnan Namboori PK, S. Jubie. Targeting a conserved pocket (n-octyl-ß-D-glucoside)on the dengue virus envelope protein by small bioactive molecule inhibitors. J Biomol Struct Dyn. DOI:10.1080/07391102.2020.1862707 (I.F:3.22)
Shyam Sundar P. SelvarajJubie, Podila Naresh, Justin A, Ashish Wadhwani, SureshKumar M. Dual Modulators of p53 and Cyclin D in ER Alpha Signaling by Albumin Nanovectors Bearing Zinc Chaperones for ER Positive Breast CancerTherapy. Mini Rev Med Chem. 2021; 21: 792. 802DOI: 10.2174/1389557520999201124212347 (I.F: 3.862).
Podila Naresh, Shyam Sunder Pottabatula, Jubie Selvaraj. Review on dengue virus fusion /entry process and their inhibition by small bioactive molecules. Mini Rev Med Chem DOI:10.2174/1389557520666200804115045. (I.F:3.862)
Selvaraj Jubie, NeetuYadav, Shyam Sundar P, Podila Naresh, Ashish Wadhwani, Jawahar Natarajan A new class of coumatebenzimidazole hybrids as BRCA 1 mimetics through unconventional binding mode; Synthesis and preliminary cytotoxicity screening..Current computer aided drug design. 2020;16: 786–801. (I.F:1.606).
Jubie Selvaraj, Jameera B.A. John, Nanjan M. Joghee, Justin Antony, Ashish Wadhwani, Jawahar Natarajan. Coumarin-fatty acid conjugates as potential ERa/AKT-1 antagonists for ER positive breast cancer. Anticancer Agents Med Chem 2020; 20:437-449. (I.F.: 2.505).
Swarupa Rani Gurram & Mohammed Afzal Azam. Design, synthesis and biological evaluation of some novel N`-(1,3-benzothiazol-2-yl)-arylamide derivatives as antibacterial agents. Published online 14th June 2021, Chem Papers. DOI: https://doi.org/10.1007/s11696-021-01730-8 [I. F.: 2.02]
Rani gurram Swarupa, Afzal Azam Mohammed. Design, synthesis, antibacterial evaluation and molecular docking studies of some newer benzothiazole containing aryl and alkaryl hydrazides. First Published: 29 May 2021. https://doi.org/10.1002/cbdv.202100117 [IF 2.039]
Vidyasrilekha Yele, Afzal Azam Mohammed, Ashish D Wadhwani. Design, Synthesis, Molecular Docking and Biological Evaluation of 2-aryloxy-N-phenylacetamide and N`-(2-aryloxyoxyacetyl) Benzohydrazide Derivatives as Potential Antibacterial Agents. Chemistry and Biodiversity. 12 February 2021. https://doi.org/10.1002/cbdv.202000907
Santhosh SB, Dutta D, Nath LK, Nanjan MJ, Chandrasekar MJN. Targeting ovarian solid tumors by pH triggered thermosensitive peptide-doxorubicin conjugate. Journal of Drug Delivery Science and Technology. 2020Oct1;59:101856.(Impact factor: 2.73)
Santhosh SB, Mohamed Sheik Tharik A, SusitraManjari M, Balakrishnan R, Muruganandam N, Chandrasekar MJN. Coronavirus disease–COVID-19: new perceptive towards epidemic to pandemic. Journal of drug targeting. 2020 Sep 13;28(7-8):755-9. (Impact factor: 3.38)
Santhosh SB, Chandrasekar MJN. Isoelectric Point Based Dual Sensitive Peptide-Drug Conjugate Prodrug to Target Solid Tumors. International Journal of Peptide Research and Therapeutics. 2020 Jan 10:1-5. (Impact factor: 2.73)
Manisha C, Selvaraj A, Jubie S, Chandrasekar MJN, Nanjan MJ, Clement JP, Justin A. Positive allosteric activation of glial EAAT-2 transporter protein: A novel strategy for Alzheimer’s disease. Medical Hypotheses. 2020 Apr 29:109794. (Impact factor: 1.39)
Santhosh SB, Natarajan D, Deepak P, Gayathri B, Kaviarasan L, Naresh P, Nanjan MJ, Chandrasekar MJN. Metabolic Enzyme Inhibitory and Larvicidal Activity of Biosynthesized and Heat Stabilized Silver Nanoparticles Using Annonamuricata Leaf Extract. BioNanoScience. 2020 Jan 4:1-2. (Impact factor: 0.92)
Santhosh SB, Chandrasekar MJN, Kaviarasan L, Deepak P, Silambarasan T, Gayathri B, Natarajan D. Chemical Composition, Antibacterial, Anti-oxidant and Cytotoxic properties of Green Synthesized Silver Nanoparticles from Annonamuricata L.(Annonaceae). Research Journal of Pharmacy and Technology. 2020;13(1):33-9. (Impact factor: 0.4)
Chandrasekar MJN, Rajeshkumar R, Arivukkarasi R. In vitro bioassessment of novel d- carboline derivatives as an antiproliferative agent. International Journal of Research in Pharmaceutical Sciences, 11(3), 3563-3568.
Chandrasekar MJN, Rajeshkumar R, Arivukkarasi R. Identification of a novel inhibitor for the Bromodomain (BRD4) through a receptor-based drug discovery approach. International Journal of Research in Pharmaceutical Sciences, 11(3), 4359-4364.
Selvaraj A, Dhananjay J, Vyshnavi T, Surender M, Sagar B, Nanjan M.J, Chandrasekar M. J. N. Structural and functional analysis of Chitinase-IV of Brassica juncea: Molecular modeling and Dynamic simulation study. Journal of Biomolecular Structure and Dynamics. 2020 DOI: 10.1080/07391102.2020.1835723 (Impact factor: 3.2)
Srikanth Jupudi, Mohammed Afzal Azam, Ashish Wadhwani. Design, synthesis and molecular modelling of phenoxyacetohydrazide derivatives as Staphylococcus aureus MurD inhibitors. Chemical Papers. 2020. https://doi.org/10.1007/s11696-020-01380-2 [IF: 1.68]
Kalirajan Rajagopal, Potlapati Varakumar, Baliwada Aparna, Gowramma Byran and Srikanth Jupudi, Identification of some novel Oxazine substituted 9-anilinoacridines as SARS-CoV-2 inhibitors for COVID-19 by Molecular docking, Free energy calculation and molecular dynamics studies. Journal of Biomolecular Structure & Dynamics, 2020 https://doi.org/10.1080/07391102.2020.1798285 [IF: 3.3]
Vidyasrilekha Yele, Afzal Azam Mohammed, Ashish D. Wadhwani. Synthesis and Evaluation of Aryl/Heteroaryl Benzohydrazide and Phenylacetamide Derivatives as Broad-Spectrum Antibacterial Agents. Chemistry Select. 2020; 5(34): 10581-10587. [IF: 1.8]
Vidyasrilekha Yele, Mohammed, Afzal Azam. Ligand-based pharmacophore modelling, in silico virtual screening, molecular docking and molecular dynamic simulation study to identify novel Francisella tularensis ParE inhibitors. Chemical Papers. July 2020;74(12):4567–4580. [IF: 1.68]
Mohammed Afzal Azam, Saha Niladri, Jupidi Srikanth. An explorative study on Staphylococus aureus MurE inhibitor: induced fit docking, binding free energy calculation and molecular dynamics. J.Recept Signal Transduct Res. 2019, 4:1-10. Doi:10.1080/10799893.1605528.
M.A.Azam, S.Jupudi, N.saha & R.K.Paul. Combining molecular docking and molecular dynamics studies for modeling Staphylococcus aureus MurD inhibitory activity. SAR and QSAR In Envir Res., 2019,1029-046X. (Impact factor : 2.22)
Mohammed Afzal Azam, Srikanth Jupudi. Structure based virtual screening to identify inhibitors against Stphylococcus aureus MurD enzyme. Structural Chemistry, 2019, doI:,10.1007/s11224-019-01330-z.
M.J.N.Chandrasekar, S.B.santhosh, M.J. Nanjan. Ovarian solid tumours:Current treatment and recent developments using stimuli-responsive polymers: A systemic review. J. of Drug Delivery Science and Technology 2019,Xxx(xxxx) xxx.xxx, (Impact factor : 2.297)
Gomathy Priya G, MJN.Chandrasekar, Rajendran .K, Carolyn K. Suzuki, S.venkatesh. In-silico design and synthesis of N9-substituted ß-Carbolines as PLK -1 inhibitors and their in – vitro/in vivo tumor suppressing evaluation. Bioorganic Chemistry, 2019,88,102913. (Impact factor : 3.92)
R. Kalirajan, K. Gaurav, A.Pandiselvi, B.Gowramma and S. Sankar, Novel thiazine substituted 9-anilinoacridines; Synthesis, Antitumour activity and structure activity relationships. Anti cancer Agents in Medicinal Chemistry. 2019,Doi:10.2174/1871520619666190408134224. (Impact factor : 2.556)
Kalirajan R, Pandiselvi A, Gowramma.B. In-Silico drug design, ADMET screening, MM-GBSA binding free energy of some Chalcone substituted 9-anilinoacridines as HER2 inhibotors for breast cancer. Int.J. of Computational & Theoretical Chemistry, 2019, 7(1), 6-13.
Pandiselvi A., Kalirajan R and Gowramma B. Molecular docking studies, insilico ADMET screening, MM-GBSA binding free energy of some novel phenyl pyrazole substituted 9-aminoacridines as HER2 inhibitors targeting breast cancer. Int. J. of Recent Scientific Res. 2019, 10,10(D), 30432-30437.
Selvaraj Jubie,Neetu Yadav, A brief review of sacffold/drug repurposing for breast cancer therapy. Anti cancer Agents in Medicinal Chemistry.2019,Doi:10.2174/1389557519666190312124142. (Impact factor : 2.556)
B.Gowramma, S.N.Meyyanathan, B.babu, N.Krishnaveni. A enw validated stability –indicating direct high-performance liquid chromatography method for the determination of Rosiglitazone enantiomers in the presence of its degradation products. Asian J. of Pharmaceutical and Clinical Res, 2019, 12(3). (Impact factor : 0.588)
Gomathy.S. S.N.Meyyanathan Gowramma.B. Stability indicatingreverse phase high performance liquid chromatography method for the simultaneous quantification of Apigenin and Luteolin from Achillea Millefolium Linn. Asian J. of Pharmaceutical and Clinical Res, 2019,12(4). (Impact factor : 0.588)
Gomathy.S, Naina Merin Joy, Shanish Antony.A. SIRTUIN 3: The most advantageous enzyme – A Review. J. of Global Trends in Pharm. Sci. 2019,10(1),6020-6030.
Dr.Md.Afzal Azam, S.Jupudi, N.Saha and R.K.Paul., Combining molecular docking and molecular dynamics studies for modeling Staphylococcus aureus MurD inhibitory activity. SAR and QSAR in Environmental Research, doi.org/10.1080/1062936X.2018 1539034.[I.F.: 2.22]
Mohammed Afzal Azam, Srikant Jupudi. Insight into the structural requirements of thiophene-3-carbonitriles-based MurF inhibitors by 3D-QSAR, molecular docking and molecular dynamics study. J Recept Signal Transduct Res. 2017; 37:522- 534. doi: 10.1080/10799893.2017.1360354 [I.F.: 1.62]
Mohammed Afzal Azam, Srikanth Jupudi. Extra precision docking, free energy calculation and molecular dynamics studies on glutamic acid derivatives as MurD inhibitors Comput Biol Chem 2017;69:55–63. [I.F.: 1.35]
M. A. Azam and J. Thathan. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors. SAR and QSAR Environ Res. 2017; 28:275-296. 10.1080/1062936X.2017.1310131 [IF: 1.897]
Venkatraj N, Nanjan MJ, Loyer P, Chandrasekar MJN, Cammas Marion S3,. J Biomater Sci Polym Ed. 2017;28:1140-1157. doi: 10.1080/09205063.2017[I.F.: 1.73]
Jubie.S,Selvaraj, Neethu Y, Parvesh B, Puru K, Shreyan A S, Chandrasekar MJN. Early stage repurposing of benzimidazole scaffolds towards breast cancer through in-silico tools. J. Pharm. Sci. & Res. 2018 10(10), 2419-2423.
Pandiselvi A., Kalirajan R and Gowramma B., Molecular docking studies, insilico ADMET screening, MM-GBSA binding free energy of some novel phenyl pyrazole substituted 9-amnoacridines as her2 inhibitors targeting breast cancer. Int. J. of recent Sci.Res, 10(01D), 30432-30437, Jan 2019.
Mohammed Afzal Azam,Janarthanan Thathan, Naga Srinivas Tripuraneni. Molecular insights on analogs of imidazo[1,2-a]pyridine, azaindole, and pyridylurea towards ParE using pharmacophore.modeling, molecular docking, and dynamic simulation. Struct Chem 2017;28:1187-1200. DOI 10.1007/s11224-017-0919-x. [I.F: 1.865]
Mohammed Afzal Azam, Naga Srinivas Tripuranenia. Pharmacophore modeling, 3D-QSAR and docking study of 2-phenylpyrimidine analogues as selective PDE4B inhibitors.J.Theo. Biol.2016; 394:117–126. [I.F.: 2.239]
Naga Srinivas Tripuraneni & Mohammed Afzal Azam. A combination of pharmacophore modeling, atom based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.J. Biomol. Struct. Dyn. 2015. DOI: 10.1080/07391102.2015.1119732.[I.F.: 3.23]
Naga Srinivas Tripuraneni, Mohammed Afzal Azam. Pharmacophore modeling, 3D-QSAR, and docking study of pyrozolo[1,5-a]pyridine/4,4-dimethylpyrazolone analogues as PDE4 selective inhibitors. J. Mol. Model 2015;21:289. DOI 10.1007/s00894-015-2837-4. [I.F.: 1.78].
Mohammed Manala, M.J.N. Chandrasekar, Jeyapal Gomathi Priya, M.J. Nanjan. Inhibitors of histone deacetylase as antitumor agents: A critical review. Bioorg Chem 2016;67:18-42. [I.F.: 2.152].
Mohammed Afzal Azam, Janarthanan Thathan, Selvaraj Jubie. Dual targeting DNA gyrase B (GyrB) and topoisomerse IV (ParE) inhibitors: A review. Bioorg Chem, 2015; 62:41-63. [I.F.: 2.152].
Mohammed Afzal Azam and Unni Jayaram. Inhibitors of alanine racemase enzyme: a review. J Enzyme Inhib Med Chem, 2016; 31:517-526. DOI: 10.3109/14756366.2015.1050010 [I.F.: 3.40].
Manal M, Manish K, Sanal D, Selvaraj A, Devadasan V, Chandrasekar MJN. Novel HDAC8 inhibitors: A multi-computational approach. SAR QSAR Environ Res. 2017,28 :707-733. doi: 10.1080/1062936X.2017.1375978 [1.F.: 1.897]
Mohammed Afzal Azam, Naga Srinivas Tripuraneni. Selective Phosphodiesterase 4B Inhibitors: A Review. Sci Pharm. 2014; 82: 453-481. doi:10.3797/scipharm.1404-08 [I.F.: 1.02].
Md. Afzal Azam, L. Dharanya, C. C. Mehta, S. Sachdeva. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating benzothiazole ring system. Acta. Pharm. 2013;63:19-30. doi: 10.2478/acph-2013-0001 [I.F.: 1.62]
R.Kalirajan, Vivek kulshrestha, S.Sankar and S.Jubie, Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their anti oxidant and anticancer activities as topo isomerase ii inhibitors, European Journal of Medicinal Chemistry, 2012; 56, 217-224.(I F 4.5)
R. Kalirajan, S. Sankar, S. Jubie, B. Gowramma,Molecular Docking studies and in-silico ADMET Screening of Some novel Oxazine substituted 9-Anilinoacridines as Topoisomerase II Inhibitors,Indian J.Pharm. Educ. Res., 2017; 51:110-115. (I F 0.27).
R Kalirajan,M H Mohammed rafick,S Sankar & B Gowramma,Green synthesis of some novel chalcone and isoxazole substituted 9-anilinoacridine derivatives and evaluation of their antimicrobial and larvicidal activities, Indian Journal of Chemistry, 2018; 57: 583-590. (I.F.: 0.65).
Kalirajan R,Gowramma B, Jubie S and Sankar S,Molecular Docking Studies and In silico ADMET Screening of Some Novel Heterocyclic Substituted 9-Anilinoacridines as Topoisomerase II Inhibitors, JSM Chemistry, 2017; 5:1039-1044.
Kalirajan R, Pandiselvi M, Sankar S and Gowramma B, Molecular Docking Studies and Insilico ADMET Screening of Some Novel Chalcone Substituted 9-Anilinoacridines as Topoisomerase II Inhibitors, SF Journal of Pharmaceutical and Analytical Chemistry, 2018; 1: 1004.
Kalirajan Rajagopal,Heterocyclic substituted 9-Anilinoacridines as Topoisomerase II Inhibitors, JSM Chemistry, 2018; 6, 1050.
Jameera Begam A, Basheer Ahamed K, ubie S, Srikanth J, Afzal Azam Md, Dhanabal SP, A new class of pure estrogen receptor angonists ; Synthesis and in-vitro screening.. Letters in drug design and discovery, 2018; 57:671-678. (IF:0.924)
A.Jammera Begam, S.Jubie, MJ.Nanjan , Review of estrogen agonists/antagonists on breast cancer therapy; A critical review. Bio organic chemistry. 2017; 71,257-274. (IF: 3.929).
Gayathri Rajamanickam, Selvaraj Jubie, Suresh Selvaraj, Thirumoorthy Rajendiran. A facile synthesis and neuroprotective role of novel quinoxaline-2,3-bis hydrazones in ethidium bromide induced demyelinated rats. Medicinal Chemistry research. 2016; 25:1403–1410. (IF: 1.607).
S.Jubie, SP.Dhanabal, MVNL.Chaitanya. Isolation of methyl gamma linolenate from Spirulina platensis using flash chromatography and its apoptosis inducing effect. BMC complementary and alternative medicine, 2015; 15.263. (IF: 2.108).
Selvaraj Jubie, Pawan Kumar Yadhav, Moola Joghee Nanjan Chandrasekar, Jeyapal Gomathi Priya, Chaitanya MVNL and Palanisamy Dhanabal. Novel fatty acid analogues as fatty acid synthase-thio esterase domain inhibitors ; Synthesis and their cytotoxicity screening. Letters in Drug Design & Discovery, 2015;12 : 495-499. (IF: 0.924).
Selvaraj Jubie, Palaniswamy Dhanabal, Mohammed Afzal Azam, Natarajan Satish Kumar, Nilesh Ambhore, Rajagopal Kalirajan. Design, synthesis and antidepressant activities of some novel fattyacid analogues. Medicinal Chemistry research. 2015; 24:1605-1616. (IF: 1.607).
S.Jubie, SP.Dhanabal, Md.Afzal azam, N.Muruganandham, R.Kalirajan, K.Elango, Synthesis and characterization of some novel fatty acid analogues: a preliminary investigation against human lung carcinoma cell line. Lipids in health and diseases, 2013;12:45.doi:10.1186/1476-511X-12-45 (IF: 2.073).
Selvaraj Jubie, Patil Nilesh Ramesh, Palanichamy Dhanabal, Rajagopal Kalirajan, Nithyanandam Muruganandam, Anthniswamy Shanish Antony. Synthesis, antidepressant and antimicrobial activities of some novel stearic acid analogues.. European Journal of Medicinal Chemistry, 2012, 54: 931-935. (IF: 4.816).
Selvaraj Jubie, Rajamanickam Gayathri, and Rajagopal Kalirajan. Synthesis and neuropharmacological evaluation of some novel quinoxaline 2,3-Dione Derivatives. The Scientific World Journal, 2012, doi:10.1100/2012/718023.
S.Jubie, P.Prabitha, R.RajeshKumar, R.Kalirajan, R.Gayathri, S.Sankar and K.Elango. Design, synthesis and docking studies of novel ofloxacin analogues as antimicrobial agents. Medicinal chemistry research. 2012; 21:1403-1410. (IF:1.607).
S.Jubie, A.Shanish Antony, Pranabesh Sikdar, R. Kalirajan, S. Gomathy, B.Gowramma and K. Elango.Synthesis and biological evaluation of some Schiff bases of [4-(amino) -5- phenyl-l 4H-1, 2, 4-triazole- 3- thiol.Pakistan Journal of Pharmaceutical Sciences, 2011; 24:109-112. (I.F.:0.804).
S.Jubie, R.Gayathri, A.R.Srividya, R.Kalirajan, P.Prabitha, S.Sankar and K.Elango, Synthesis and characterization of some novel quinoxaline-2, 3-dione derivatives: a preliminary investigation on their activity against human epithelial carcinoma cell line. Letters in Drug Design & Discovery, 2011; 8, 317-320. (IF: 0.924).
S.Jubie, R.Kalirajan and Pavan Kumar Yadav, Design, synthesis and docking studies of a novel ciprofloxacin analogue as an antimicrobial agent. E-journal of chemistry, 2012, 9:980-987. (IF : 1.726).
S Jubie, B Bincy, A Jameera Begam, W Ashish, R Kalirajan & Md Afzal Azam, A new class of human fatty acid synthase inhibitors: Synthesis and their anticancer evaluation., Indian Journal of Chemistry, 2018; 57 : 671-678, (F : 0.566).
S.Jubie, S.Meena, K.V.Ramseshu, N.Jawahar and S.Vijaykumar. Synthesis and biological evaluation of some hydrazones and carbazones of Indane -1,3- dione. Indian Journal of Chemistry, 2010;49 :1261-1263. (IF 0.566)
B. Gowramma, T. K. Praveen, S. Gomathy, B. Babu , R. Kalirajan and N. Krisnaveni Synthesis of 2-(bis (2-chloroethyl) amino)-n`-(5-substitutedphenyl)- 1,3,4-thiadiazol-2-yl)acetohydrazide and evaluation of anticancer activity. Current bioactive compounds, 2018;14: 309-316.
B. Gowramma,T. K. Praveen, R. Kalirajanand B. Babu. Synthesis of some novel 2-azetidinones/4-thiazolidinones bearing 1, 3, 4-thiadiazole nucleus and screening for its anti-inflammatory activity. Letters in drug design and discovery, 2016;13 : 676-683.
Gomathy Subramanian, Subramania Nainar Meyyanathan, Byran Gowramma and Dhanabal S. Palanisamy. Liquid chromatography-mass spectrometric method for simultaneous estimation of apigenin and luteolin from Achillea millefolium Linn. Asian Journal of Research in Chemistry, 2016;9:629-632.
A.Shanish Antony, S. Gomahty, T.P.Rajmohan, P.Anoop, Cijo Issaic. Pharmacological evaluation of curcumin for its nephroprotective activity in 5/6 nephrectomized rat model, Drug invention Today; 2018;10:11-13.
Gomathi Priya Jeyapa, M.J.N. Chandraseka, Rajendiran Krishnasam, Jubie Selvara, Manal Mohamma and M.J. Nanjan Potential Pharmacological Inhibitors of Pim Kinase Under Clinical Trials. Anti-Cancer Agents in Medicinal Chemistry, 2018; 10.2174/1871520618666180131113519 [IF: 2.633]
A. Jameera Begam,A.basheer, Selvaraj Jubie, Srikanth Jupudi, Mohammed Afzal Azam and Palanisamy Dhanabal. A new class of pure estrogen alpha receptor antagonists: Design, symthesis and in-vitro screening. Letters in Drug Design & Discovery, 2018, 15. .[I.F.:1.1]
Blaise K Nganou, James D, Simo Mpetga, Jubie S, Chaitanya Mvn, Dhanabal Palanisamy, Antony H, Nkuetea and Pierre Tane., A brief review on Agauria salicifolia : A Mediterranean Plant Species. J. Pharm. Sci. & Res. 2018,10(10), 2428-2430. [I.F.: 0.5]
Jeyapal GP, Chandrasekar MJN, Krishnasamy R, Selvaraj J, Mohammad M, Nanjan MJ. Potential Pharmacological Inhibitors of Pim Kinase Under Clinical Trials. Anticancer Agents Med Chem. 2018;18(8):1100-1114. doi: 10.2174/1871520618666180131113519
Elizabeth Eldhose, B.Gowramma, Manal Mohammed, R.Kalirajan, L.Kaviarsan. Translational chemiotherapy for hiiple negative breast cancer – A review in significance of poly (ADP-ribose) polymase 1(PARP1) inhibitors. J. of Pharmacy and Technology, 2019, 12(6), 1-7
Vedpal, Srikanth Jupudi, Jubie.S, N.P.Deepika and S.P.Dhanabal. A new pyrimidine alkaloid from the roots of Tadehagi triquetrum (L.) H.Ohashi. Natural product Research, 2019, doi.org/10.1080/14786419.2019.1634716
Vidyasrilekha, Niladri saha, Afzal Azam Md. Possible role of rivoglitazone thiazolidine class of drug as dual-target therapeutic agent for bacterial infections: An in silico study. Medical Hypotheses, 2019,131,109305. I.F.: 1.322
Selvaraj Jubie, basher A, Neetu Yadav, Ashish Wadhwani, Mohammed Afzal Azam. Synthesis and evaluation of coumate analogues as estrogen receptor inhibitors for breast cancer therapy. Int.J. of Res.Pharm.Sci., 2019,10(3), 2218-2224
BlaiseKnganou, JubieS,Pierre Tane, AlexNchiozem, Ingrid Simo,ChaitanyaMVNL, Dhanabal Palanisamy. A review on adenocarpus mannii; a Main species of the Genus Adenocarpus. Current Traditional medicine, 2019,DOI:10.2174/2215083805666190708153634
Mohammed Afzal Azam, Srikanth Jupudi and Ashish Wadhwani. Synthesis , molecular docking, binding free energy calculation and molecular dynamics simulation studies of benzothiazol-2-ylcarbamodithioates as Staphylococcus aureus MurD inhibitors. J. of Receptors and Signal Transduction, 2019,39 (3), 283-293. I.F.:1.63
Byran Gowramma, Swathi Krishna, Manal Mohammed, T.K.Praveen, R.Kalirajan, L.Kaviarasan. Synthesis, In sil;ico and in vivo evaluation of novel 1,3,4-thiadiazole analogues as novel anticancer agents. Letters in Drug Design and Discovery, 2019,DOI: 10.2174/1570180816666190710145939. I.F.: 0.953
Jubie.S, Dual evaluation of some novel chalcone annualated pyrazolines as anti- inflammatory and antimicrobial agents via in-silico target study on cyclooxygenase-2. Int. J. of Res. In Pharm. Sci., 2019,10(4), 3159-3169
Jubie.S, In-silico docking studies of phytometabiolites from traditional plant rujamari (rosmarinus officinalis) against human topoisomerases i&ii. Int. J. of Res. In Pharm. Sci., 2019,11(4),918-934
Jubie.S, Coumarin-Fatty acid conjugates as potential ERa/AKT-1 antagonists for ER positive breast cancer. Anti cancer agents in Medicinal Chemistry, 2019,DOI: 10.2174/1871520619666191028104339. I.F.: 2.15
Gowramma B, Kumar RS, Kalirajan R, Lakshmanan K, Meyyanathan SN, Enantiomeric separation of Meclizine hydrochloride in Pharmaceutical dosage form by HPLC method.Curr Drug Res. Rev., 2019, DOI: 10.2174/2589977511666191211123337. I.F.: 2.5
Mohammed Afzal Azam, Janarthanan.T, Srikanth Jupudi, Pharmacophore modeling, atom based 3D- QSAR, molecular docking and molecular dynamic studies on Escherichia coli ParE inhibitors, Computational biology and Chemistry2020, 84, 107197, I.F.: 1.5
Mohammed Afzal Azam, Srikanth Jupudi, MurD inhibitors as antibacterial agents: a review, Chemical Papers, 2020.10.1007/s11696-020-01057-w, I.F.:1.2
S.B.Santhosh, MJN.Chandrasekar, Iso electric point based dual sensitive peptide-drug conjugate pro drug to target solid tumors, Int. J. of Peptide Res. And Therapeutics, 2020. 10.1007/s10989- 020-10022-w, I.F.:1.219
S.B.santhosh, D.Natarajan, P.Deepak, B.gayathri, L.Kaviarasan, P.Naresh,MJ.Nanjan, MJN.Chandrasekar, Metabolic enzyme inhibitory and larvicidal activity of biosynthesized and heat stabilized silver nanopartices using Annona muricata Leaf Extract, Bionanoscience, 2020,10.1007/s12668-019-00709-w
S.B.Santhosh, MJN.Chandrasekar, KaviarasanL, P.Deepak, T.Silambarasan, BGayathri, D.Natarajan, Chemical composition, antibacterial, anti-oxidant and cytotoxic properties of green synthesized silver nanoparticles from Annona muricata L. (Annonaceae), Res. J. of Phar. And Tech,2020, 13(1) ,1-7
Jubie.S,JameeraB.A.John, Nanjan M.Joghee, Justin Antony, Ashish Wadhawani and Jawahar .N, Coumarin –fatty acid conjugates as potential ERa/AKT-1 antagonists for ER positive breast cancer, Anticancer agents in Med.Chem. 2020.10.2174/1871520619666191028104339
Tahngavelu Prabha, Selvaraj Jubie, Thangavel Sivakumar, Palanisamy Selvamani, Subbiah Latha, Gunasundaram Kiruthika. 3D-QSAR validation of coumarin sulphonamide derivatives for the prediction of anti-cancer potency of coumarin chalcone Imine conjugates, Int. j. of Pharm Res.2020, 10(2)69-77
Gomathy Subramanian, Mithra, Gowramma Byran, farhath Sherin, Ashish D. Waddhwani. Synthesis and anti-microbial screening of some novel N-(5-benzyl-1,3,4-oxadiazol-2-yl)-2-chloroacetamide samino derivatives. World j. of Pharmacy and Pharm.Sci., 2020, 9(1),1189-1198
Dr.R.kalirajan, K.Guarav, A. Pandiselvi, B.Gowramma and S.sankar, Novel thiazine substituted 9- anilinoacridines: Synthesis, antitumour activity and structure – activity relationships, Anti-Cancer Agents in Medicinal Chemistry, 2019,19, 1350-1358
Dr.R.kalirajan, A. Pandiselvi, B.Gowramma, P.Balachandran, In –silico design, ADMET screening, MM-GBSA binding free energy of some novel isoxazole substituted 9-anilinoacridines as HER2 inhibitors targeting breast cancer, Current Drug Research Reviews, 2019, 11, 118-128
Pharmacophore modeling, atom based 3D-QSAR, molecular docking and molecular dynamics studies on Escherichia coli ParE inhibitors. Mohammed Afzal Azam, Janarthanan Thathan, Srikanth Jupudi. Comput Biol Chem 2020;84:107197 [I.F.: 1.58]
S. B. Santhosh, M. J. N. Chandrasekar. Isoelectric Point Based Dual Sensitive Peptide-Drug Conjugate Prodrug to Target Solid Tumors. Int J Pep Res Therap. https://doi.org/10.1007 /s10989-020-10022-w [I. F.: 1.21]
S. B. Santhosh, D. Natarajan, P. Deepak, B. Gayathri, L. Kaviarasan, P. Naresh, M. J. Nanjan, M. J. N. Chandrasekar. Metabolic Enzyme Inhibitory and Larvicidal Activity of Biosynthesized and Heat Stabilized Silver Nanoparticles Using Annona muricata Leaf Extract. BioNano Sci. https://doi.org/10.1007/s12668-019-00709-w [I. F.: 0.92]
Mohammed Afzal Azam, Srikanth Jupudi. MurD inhibitors as antibacterial agents: a review. Chem Papers (2020) 74:1697- 1708. https://doi.org/10.1007/s11696-020-01057-w [I.F.: 1.22]
Vidya SY, Niladri S, Afzal AMD. Possible role of rivoglitazonethiazolidine class of drug as dual-target therapeutic agent for bacterial infections: An in silico study. Med Hypoth 2019, 10; 13:109305. (IF: 1.322)
Mohammed AA, Srikanth J, Ashish W. Synthesis, molecular docking, binding free energy calculation and molecular dynamics simulation studies of benzothiazol-2-ylcarbamodithioates as Staphylococcus aureusMurD inhibitors. J Recept Sig Transduct 2019, 6; 39: 283-293. (IF: 1.63)
Byran G, Swathi K, Manal M, Praveen TK, Kalirajan R, Kaviarasan L. Synthesis, In silico and in vivo evaluation of novel 1,3,4-thiadiazole analogues as novel anticancer agents. Lett Drug Desi Discov 2019; 17: 434-444. (IF: 0.953)
Kalirajan R, Guarav K, Pandiselvi A, Gowramma B, Sankar S. Novel thiazine substituted 9-anilinoacridines: Synthesis, antitumour activity and structure-activity relationships. Anticancer Agents Med Chem 2019; 19:1350-1358. (IF: 2.18)
Selvaraj J, Neetu Y, Shyam SP, Podila N, Ashish W, Jawahar N. A new class of coumatebenzimidazole hybrids as BRCA 1 mimetics through unconventional binding mode; Synthesis and preliminary cytotoxicity screening. Curr Comput Aided Drug Des 2019;12. (IF:1.098). (IF: 1.35)
Santhosh SB, Chandrasekar MJN. Iso electric point based dual sensitive peptide-drug conjugate pro drug to target solid tumors. Int J Pep Res Therap 2020; 01. (IF: 1.219)
Jubie S, JBA John, Joghee NM, Justin A, Ashish W, Jawahar N. Coumarin-fatty acid conjugates as potential Era/AKT-1 antagonists for ER positive breast cancer. Anti-Cancer Agents Med Chem 2020; 10:20: 437-449. (IF:2.18)
Sravanthi B, Kaviarasan L, Praveen TK, Pindiprolu SSSK, Pavankumar C, Gowramma B. Synthesis and Pharmacological Evaluation of 1, 3, 4-Thiadiazole bearing Pyrimidine Derivatives as STAT3 Inhibitor for Treatment of Breast Cancer. J Iranian Chem Soc 2020; 4. (IF: 1.475)
Kaviarasan L, Gowramma B, Kalirajan R, Mevithra M, Chandralekha S. Molecular docking studies and synthesis of a new class of chroman-4-one fused 1,3,4-thiadiazole derivatives and evaluation for their anticancer potential. J Iranian Chem Soc. 2020;3. (IF:1.475)
Vidyasrilekha Yele, Afzal Azam Mohammed, Ashish D. Wadhwani. Synthesis and Evaluation of Aryl/Heteroaryl Benzohydrazide and Phenylacetamide Derivatives as Broad-Spectrum Antibacterial Agents. ChemSelect. 2020 https://doi.org/10.1002/slct.202002178
Mohammed Afzal Azam, Vyshaag Chembakam veetil Manoj. An explorative study on diarylquinoline based inhibitor targeting Enterococcus faecium MurF. Struct Chem Aug’2020 https://doi.org/10.1007/s11224-020-01622-9
Md. Afzal Azam, Srikant Jupudi, MurD inhibitors as antibacterial agents: a review Chem Papers Jan’ 2020 DOI: 10.1007/s11696-020-01057-w
Mohammed Afzal Azam, Janarthanan Thathan, SrikanthJupudi . Pharmacophore modeling, atom based 3D-QSAR, molecular docking and molecular dynamics studies on Escherichia coli ParE inhibitors. Comput Biol Chem 2020;84:107197 https://doi.org/10.1016/j.compbiolchem.2019.107197
Niladri Saha, Mohammed Afzal Azam. MurE inhibitors as antibacterial agents: a review. J Incl Phenom Macrocycl Chem Aug’ 2020. https://doi.org/ 10.1007/s10847-020-01018-6
Vidyasrilekha Yele, Afzal Azam, Ligand-based pharmacophore modelling, in silico virtual screening, molecular docking and molecular dynamic simulation study to identify novel Francisella tularensis ParE inhibitors. Chem Papers July 2020;74:4567–4580 DOI: https://doi.org/ 10.1007/s11696-020-01274-3
Vidyasrilekha Yele, Md. Afzal Azam, Srikant Jupudi. Exploitation of Pare Topoisomerase IV as Drug Target for the Treatment of Multidrug-Resistant Bacteria: A Review. Aug’ 2020;54:462 DOI: https://doi.org/10.1007/s11094-020-02223-w
Ongoing Project
Dr.S.Jubie - Development of BRCA-1 mimetiec(s) for breast cancer therapy; An insilico approach. Funding Agency : AICTE –RPS, New Delhi. Rs. 7,00,000 lakhs. Duration : 3Years.
Patents Published:
Mono-esterification process for the synthesis of carboxymethyl chitosan hybrid with WZB117.K.Gowthamarajan, S.Jubie,Anindita De.(File No.202041008119; Published on 30.12.2020).
Patents
Isolation of sulphaquinovosyldiacyl glycerol (SL) (A human topopoison 1) using flash chromtatography.SP.Dhanbal, S.Jubie, MVNL Chaitanya (IN:352435) Awarded on 21.11.2020.
“5-heptadeca-5, 8, 11-trienyl 1, 3,4- oxadiazole-2thiol (gla-1) a human topo-poison and synthesis thereof”. (IN:365340 ) (File No. 201741010450); Awarded on 26.04.2021).
Published patent entitled “Composition of a copper-quercetinnano complex for treating human papilloma virus infected cervical” having file number 761/CHE/2013 in collaboration with Department of Pharmaceutics
Filed patent on “Isolation of 5-heptadec-5, 8, 11-trienyl-1, 3, 4-oxadiazole-3-thio (GLA-1) as a novel human topo poison lead” bearing file number 201741010426/2017 in collaboration with Department of Pharmacognosy and Phytochemistry.
Filed a patent on “Isolation of sulphaquinovosyldiacyl glycerol (SL) (A human topopoison 1) using flash chromatography” bearing file number 201741010450/2017 in collaboration with Department of Pharmacognosy.
Online Application 2024
Enquire Now